NVS-PAK1-C is primarily utilized in the field of cancer research and drug development. It serves as a potent and selective inhibitor of p21-activated kinase 1 (PAK1), which is implicated in various cellular processes such as cell motility, proliferation, and survival. By inhibiting PAK1, this compound helps in studying the role of PAK1 in tumor growth and metastasis, making it a valuable tool for understanding cancer biology. Additionally, it is used in preclinical studies to evaluate its potential as a therapeutic agent for cancers where PAK1 signaling is dysregulated, such as breast and ovarian cancers. Its application extends to screening assays to identify and validate new drug candidates targeting PAK1-related pathways.